Showing 7,981 - 8,000 results of 18,540 for search 'significantly ((((((lower decrease) OR (linear decrease))) OR (a decrease))) OR (larger decrease))', query time: 0.74s Refine Results
  1. 7981

    Table 1_Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database.xlsx by Shanshan Wu (348762)

    Published 2025
    “…Notably, NCDIA-associated mortality rates showed a significant decrease from 11.91% (2004–2010) to 7.28% (2021–2024) (P < 0.001).…”
  2. 7982

    Image 1_Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database.pdf by Shanshan Wu (348762)

    Published 2025
    “…Notably, NCDIA-associated mortality rates showed a significant decrease from 11.91% (2004–2010) to 7.28% (2021–2024) (P < 0.001).…”
  3. 7983

    A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer’s disease by Akanksha Chhabra (71080)

    Published 2024
    “…</p> <p>According to CDR-SB measurements, lecanemab showed effectiveness in reducing brain amyloid and cognitive decline, with a change from baseline of 1.21. Aducanumab resulted in a decrease of −0.39 (−22%). …”
  4. 7984

    Water Hyacinth as a Renewable Source of Cellulose Nanofibers: Fabrication and Properties of Optically Transparent Nanocomposites by Supachok Tanpichai (2084065)

    Published 2024
    “…Moreover, the CNF nanopaper significantly decreased the coefficient of thermal expansion of the acrylic resin from 192.3 to 16.3 ppm K<sup>−1</sup>, which is comparable to that of borosilicate glass. …”
  5. 7985

    NWB2024_A change of monograph publication patterns after the implementation of the Polish Publishers List by Emanuel Kulczycki (98040)

    Published 2024
    “…The number of monographs published by publishers not included in PPL significantly decreases while there is a noticeable upward trend in the publication of monographs with Level 2 publishers noted for their prestige and alignment with international standards. …”
  6. 7986
  7. 7987

    Noninvasive neurally-adjusted ventilatory assist in preterm infants: a systematic review and meta-analysis by Yohei Minamitani (19853854)

    Published 2024
    “…</p> <p>In a small cohort with low certainty of evidence, NIV-NAVA may prevent reintubation in preterm infants. …”
  8. 7988

    Supplementary Material for: A common variant in NID1 gene associated with the prognosis of heart failure by figshare admin karger (2628495)

    Published 2025
    “…Western blot analysis demonstrated that the protein level of NID1 was significantly higher in the rs3738530-T allele compared to the A allele (P < 0.05). …”
  9. 7989

    Raw data. by Adrian Bartoszek (20826922)

    Published 2025
    “…Seizures were induced by adding PTZ to achieve a final concentration of 20 mM. In the PTZ-induced seizure model, the application of CAF in doses over 50 mg/L resulted in a decrease in the average movement. …”
  10. 7990

    Table 1_How long do pathogens persist and survive in water? A systematic review.docx by Famous K. Sosah (22509419)

    Published 2025
    “…Bacteria were the most studied group, with a mean survival of 28 days and persistence up to 621 days, especially at lower temperatures and in freshwater. …”
  11. 7991

    Driving variables recorded from the simulator. by Mobina Faqani (22783963)

    Published 2025
    “…Additionally, HF conversation was associated with a decrease in ART among conservative participants, while it significantly increased TIBL for both moderate and conservative groups. …”
  12. 7992
  13. 7993

    Table 1_Survival assessment in extremely preterm neonates in a middle-income setting.docx by Maria J. Rodriguez-Sibaja (17456689)

    Published 2025
    “…Overall mortality decreased with increasing gestational age, from 100% (22/22) at <24.0 weeks of gestation to 87% (14/16), 42% (16/38), and 21% (11/52) at a gestational age of 25, 26, and 27 weeks, respectively. …”
  14. 7994

    Table 2_Survival assessment in extremely preterm neonates in a middle-income setting.docx by Maria J. Rodriguez-Sibaja (17456689)

    Published 2025
    “…Overall mortality decreased with increasing gestational age, from 100% (22/22) at <24.0 weeks of gestation to 87% (14/16), 42% (16/38), and 21% (11/52) at a gestational age of 25, 26, and 27 weeks, respectively. …”
  15. 7995

    Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
  16. 7996

    Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
  17. 7997

    Image 2_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
  18. 7998

    Table 1_Gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review.docx by Beibei Zhang (509356)

    Published 2025
    “…At diagnosis, OC patients displayed gut dysbiosis characterised by an increase in Proteobacteria and a decrease in Firmicutes. Genus-level analysis revealed lower levels of Akkermansia and elevated levels of Bacteroides and Prevotella, suggesting disrupted microbial homeostasis. …”
  19. 7999

    Data Sheet 1_Polyphenol-mediated microbiome modulation in STEMI patients: a pilot study.zip by Argul Issilbayeva (21398168)

    Published 2025
    “…</p>Conclusion<p>Our findings demonstrate that polyphenol supplementation maintains stable TMAO levels by restructuring gut microbiome composition in STEMI patients, evidenced by a more focused microbiome with a significant increase in beneficial butyrate-producing bacteria (Roseburia, Agathobaculum sp., Alistipes finegoldii, and Sellimonas) and a decreased Firmicutes/Bacteroidetes ratio, suggesting microbiome-mediated cardioprotective effects. …”
  20. 8000